Medidata Sustainability Profile
Medidata Solutions, Inc., headquartered in the United States, is a leading player in the life sciences industry, specialising in cloud-based solutions for clinical trials. Founded in 1999, the company has achieved significant milestones, including the development of innovative technologies that streamline the drug development process. With a strong presence in North America, Europe, and Asia, Medidata offers a comprehensive suite of products and services, including data management, analytics, and patient engagement tools. Their unique platform integrates advanced analytics and artificial intelligence, enabling biopharmaceutical companies to enhance decision-making and improve trial outcomes. Recognised for its market leadership, Medidata has been instrumental in transforming clinical research, supporting over 25,000 trials and 5 million patients globally. The company’s commitment to innovation and excellence positions it as a trusted partner in the evolving landscape of clinical development.
DitchCarbon Score
How does Medidata's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medidata's score of 53 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medidata's reported carbon emissions
In 2023, Medidata reported total carbon emissions of approximately 936,000 kg CO2e, comprising 52,000 kg CO2e from Scope 1, 40,000 kg CO2e from Scope 2 (market-based), and 836,000 kg CO2e from Scope 3 emissions. This data reflects a comprehensive approach to emissions reporting, including all relevant scopes. Medidata's emissions data from previous years shows a significant reliance on Scope 3 emissions, which accounted for the majority of their carbon footprint. For instance, in 2019, Scope 3 emissions reached about 15,514,000 kg CO2e, indicating a substantial area for potential reduction. To address their environmental impact, Medidata has set near-term targets aimed at achieving a fossil fuel-free fleet of company cars by 2025, which is expected to reduce both Scope 1 and Scope 2 emissions. This initiative is part of their broader commitment to combat climate change and enhance air quality. The emissions data is cascaded from Medidata Solutions, Inc., a current subsidiary of Dassault Systèmes SE, which influences their sustainability strategies and targets. Medidata's commitment to reducing emissions aligns with industry standards and reflects a proactive stance towards achieving net-zero emissions in the near future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | 000,000 | 000,000 | 00,000 |
| Scope 2 | 1,831,000 | 0,000,000 | 0,000,000 | 00,000 |
| Scope 3 | 6,330,040 | 00,000,000 | 00,000,000 | 000,000 |
How Carbon Intensive is Medidata's Industry?
How Carbon Intensive is Medidata's Location?
Medidata's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medidata has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
